COSA 2013* #1 – Meeting the Challenges of Cancer in the Elderly#10 – Exercise and Genitourinary Cancer Survivorship#100 – Patterns of Care of Elderly Patients with Metastatic Colorectal Cancer#101 – Self-Reported Geriatric Assessment Predicts Poor Outcomes in Elderly Cancer Patients.#102 – Effectiveness of a community based exercise program for cancer survivors#103 – Differential impact of aerobic fitness and muscular strength on bone health, body composition, physical function and patient reported outcomes in men with prostate cancer#104 – Chemotherapy Induced Nausea and Vomiting (CINV) in the Αsia-Pacific (ΑΡ) Region – The Australian Perspective from the Ρan-Australasian Chemotherapy Induced Emesis Study (PrACTICE)#105 – Psychosocial predictors of survival in women with invasive ovarian cancer: a population-based prospective study#106 – A multicenter year-long randomized controlled trial of exercise training targeting cardiovascular risk factors and physical functioning in older men with prostate cancer#107 – A Longitudinal, Prospective Study Evaluating Fatigue and Quality of Life in Colorectal Cancer (CRC) Patients#108 – Do we have to keep patients on treatment forever? When is it OK to stop?#109 – The Potential for Freedom from Adjuvant Chemotherapy: An Under-Recognized Benefit of Surgical Therapy for Colorectal Liver Metastases#11 – Translating Evidence into Practice: Incorporating Exercise into Standard Cancer Care#110 – What is the optimal length of neo-adjuvant therapy?#111 – Cancer Survivorship Issues in Patients with Gastrointestinal Cancers#112 – Introduction to sexuality and cancer, psycho sexual issues and interventions#113 – Male sexuality and cancer: The impact below the belt#114 – Assessing and Responding to Psychosexual Concerns of Older People with Cancer#115 – Developing Health Professional’s Capabilities in the Provision of Psychosexual Care#116 – Do old patients need more holidays than younger patients?#117 – The Ageing Population and its Relevance to Colorectal Cancer Surgery#118 – Quality of life in patients with anorectal cancer treated with combined therapy#119 – Toxicity of Chemotherapy in Elderly Patients with Colorectal Cancer#12 – Cancer 2015 – Cross-Disciplinary Research of a Genomic Cancer Cohort#120 – Recent developments in therapeutics and interventions in palliative care#121 – Palliative Care Systems: Evidence for Key Models of Care Elements#122 – Ehealth in palliative care#123 – The evidence base for rehabilitation in palliative care#124 – Cancer Care in the Context of Comorbidity#125 – How Does Cancer Interact with Comorbidity?#126 – Cancer, Comorbidity and Care: the prevalence and importance of comorbidity in cancer#127 – Comorbidities and Cancer Survival: A Comparison between Indigenous and Non-Indigenous Australians#128 – The Role of Comorbidity in Cancer Care Decision-Making in Multidisciplinary Teams#129 – Self-Management of Comorbidity and Recovery after Colorectal Cancer: A Phase I/II Study#13 – Cancer 2015 – Genome Defined Cancer Risk#130 – Should Abdominoperineal Resection Rate be used as a Surrogate Marker of Hospital Quality in Rectal Cancer Surgery?#131 – An Observational Study Exploring the Survival Differences for Advanced Cancer Patients Treated in Metropolitan Perth Compared to Rural Western Australia (WA)#132 – Findings from a Systematic Review on Cancer Care Coordinators#133 – Health Service Use, Treatment Patterns, and Survival for Cancer of Unknown Primary: A Data Linkage Study#134 – Quality of life and other patient reported outcomes following pelvic exenteration for pelvic malignancy: prospective, comparative study#14 – Cancer 2015 – Early Molecular Pathology Insights#141 – Validating a novel, low cost, automated malnutrition screening system as a predictor of nutritional risk in the Oncology Day Care Unit#143 – The rising cost of anti-cancer drugs in Australia#144 – Patterns of care in elderly patients with resected non-small cell lung cancer (NSCLC) in South Western Sydney Local Health District (SWSLHD)#145 – Use and Cost of Chemotherapy in Australia between 2000 and 2011#146 – Evidence Confirming Intermittent Androgen Deprivation as Rational Standard-Of-Care Treatment for Metastatic Prostate Cancer: A Meta-Analysis of Pooled Data from 5405 Patients with Fixed Effect Modelling#147 – Pancreatico-Duodenectomy With High Quality Results in a Medium Volume Centre. What Are the Australian Definitions of Low Volume#148 – How is Cancer Research Reported by the Cancer Council’s Cancer Daily News#149 – Safety and Efficacy of Esophageal Stents Preceding or During Neoadjuvant Chemotherapy for Esophageal Cancer: A Systematic Review and Meta-Analysis#15 – Cancer 2015 – Health Economic Perspective on Cancer Care#150 – Colorectal cancer surgery rates in indigenous versus nonindigenous patients#151 – Caring for women with ovarian cancer in the last year of their life: Impact on the caregiver. #152 – Physical activity predictors and preferences among gynaecological cancer survivors.#153 – How are Geriatric Assessment Domains and Age Discussed in Cancer Multidisciplinary Meetings?#154 – Do Men with Prostate Cancer and their Partners Receive the Information and Support they Need for Optimal Illness Self-Management?#155 – Pancreatic cancer patient’s moderate or high unmet supportive care needs over time and risk factors of future unmet needs#156 – Immune Genetic Variability is Associated with Risk of Severe Gastrointestinal Toxicity in Patients Treated with Fluorouracil#157 – Understanding the Distress and Coping of Men with Cancer Indicates the Integration of Comprehensive and Accessible Information into Standard Treatment Paths#158 – Stress and burnout, work engagement and meaningful work in psychosocial health professionals working in Oncology. #159 – Traditional Indigenous medicine and complementary medicine use amongst Indigenous cancer patients in Queensland, Australia#16 – Cancer 2015 – Global Perspectives on Genomic Cohorts#162 – Psychosocial Distress Screening in Oncology: A Qualitative Study of Health Professionals.#163 – Lung Cancer in Rural and Remote Aboriginal and Torres Strait Islander Communities in Queensland#164 – An Audit and Evaluation of the Lung Cancer Journey: Metropolitan and Non - Metropolitan#165 – Compliance with nutrition prescription in patients with Head and Neck Cancer undergoing radiotherapy: a descriptive study#167 – DENOSUMAB induced Hypocalcaemia in Advanced cancers at the Top End; Severity and Management#17 – Clinical practice guidelines for the management of central nervous system metastases in women with secondary breast cancer#170 – RCT of Colonic Stent Insertion vs. Surgical Decompression for Patients with Malignant Incurable Large Bowel Obstruction#171 – Monitoring clinical studies – improving quality#172 – Evaluation of an Education Program to Facilitate Patient Adherence, Toxicity Monitoring and Promote Safety and Wellbeing in the Self Administration of Oral Chemotherapy in the Home Setting#173 – A Drug-Interaction Study of Effects of Calcium and Magnesium Infusions on Oxaliplatin Pharmacokinetics, Motor Nerve Hyperexcitability and Acute Neurotoxicity Symptoms in Colorectal Cancer Patients#174 – Retrospective Review of Hypersensitivity Reactions to Paclitaxel with Oral Versus Intravenous Dexamethasone, Antihistamine and H2-Antagonist Premedication.#175 – Granulocytic Sarcoma of the Bladder as the Sole Manifestation of Acute Myelogenous Leukemia: a case report and literature review#176 – Development of Guidelines to Inform the Content of Summarized Patient Information Forms (SPIFs) Regarding Cancer-Related, Clinical Trials#177 – Survival of Patients with Resected Cerebral Metastases from Gastrointestinal Cancers#178 – A Pilot Study of a Healthy Lifestyle Self-Management Intervention with Cancer Survivors#179 – Late Effects of Oxaliplatin-induced peripheral Neuropathy (LEON)#18 – Development and Early Outcomes of the Find Cancer Early Community Education Campaign in Regional Western Australia.#180 – CHARM Utility study#181 – Monitoring and treatment of hypomagnesaemia in patients receiving cetuximab#183 – A Prospective Study of Anti-Mullerian Hormone (AMH) As a Potential Predictor of Chemotherapy-Induced Menopause: Preliminary Results.#184 – An introduction to ICCon - Inherited Cancer Connect Partnership#185 – Physical Activity (PA) Participation for Women with Ovarian Cancer#186 – Factors Predictive of Tumor-Positive Nonsentinel Lymph Nodes after Positive Sentinel Lymph Node Biopsy in Melanoma Patients: Westmead Melanoma Unit Experience and a Review of Literature #187 – Metastatic central nervous system recurrence in breast cancer: Impact of tumour sub-type#188 – The Prostate Cancer Journey: Results of an Online Survey of Men and their Partners.#189 – Impaired Sexual Function and Prostate Cancer; A Mixed Method Investigation into the Experiences of Men and their Partners#19 – Clinical practice guidelines for the management of breast cancer in women with an identified BRCA1 or BRCA2 gene mutation or at high risk of a gene mutation#190 – Audit of Patient Selection and Protocols for Prostate Cancer Active Surveillance in South Australia#191 – Qualitative Results of the LEON study: Late Effects of Oxaliplatin-Induced Peripheral Neuropathy#192 – Incidence of gastrointestinal toxicity with capecitabine monotherapy in metastatic breast and metastatic colorectal cancer patients #193 – Barriers to Recruitment for a Post-Cancer Fatigue Intervention Study - The TOPS Trial.#195 – Hypocalcaemia in patients with metastatic bone disease (MBD) receiving denosumab#196 – Meta-Analysis of Progression-Free Survival Impact of Biological Therapy in Relapsed Metastatic Colorectal Cancer#197 – Audit Versus Actual Recruitment in Palliative Care Clinical Trials#198 – Communication between Health Professionals and Cancer Patients about Integrative, Complementary and Alternative Therapies: Exploring Different Perspectives#199 – Current Australian Research Activity Investigating Complementary and Integrative Therapies in Oncology: A Survey of COSA Members#2 – Geriatric Oncology – What is it and why do we need it?#20 – The Effect of the New Selective GLP-2 Agonist, Elsiglutide, On Irinotecan-Induced Diarrhoea and Mucositis in the Rat.#201 – Student Perceptions of a Consumer Led Discussion Group Format to Improve Awareness of the Patient Perspective#202 – A Randomised Controlled Trial to assess the impact of a cognitive dissonance intervention to alter attitudes and intentions to tan among young adults in Australia.#203 – Inpatient Chemotherapy Service Improvement Project#204 – Quit Or Quiet? High Smoking Prevalence, Low Disclosure Rates and Low Smoking Cessation Program Participation Rates among Cancer Patients#205 – Palliative Car Referrals and Time Period between Last Chemotherapy and Death in Metastatic Breast Cancer Patients in North Queensland.#206 – Cancer Coping Online: Findings and lessons learned from a phase II RCT of an eHealth program for reducing cancer-distress.#21 – The Biology of Fertility Loss in Oncology Patients and Advances in Fertility Preservation Strategies#210 – COSA Position Statement - The Use of Complementary and Alternative Medicine by Cancer Patients#211 – Analysis of Pharmacist role in Haematology and Oncology at Royal Darwin Hospital#212 – Identifying and addressing the supportive care needs of the ‘complex’ patient with Multiple Myeloma within a Nurse Practitioner led service#213 – Victorian Patient Management Framework: Achievements and future directions#214 – Navigating Indirect Utility Models in Cancer: Mapping the EORTC QLQ-C30 onto the EQ-5D#215 – Assessing the Value of Precision Therapies in the Multi-Omics Era of Medicine#216 – Community Oncology: Patients’ perspective on a rural Australian medical oncology outreach service#217 – Feasibility study of an oncology nurse practitioner model of care in a rural cancer setting#218 – Service Mapping the Flow of Care for Chemotherapy Outpatients at Sir Charles Gairdner Hospital#22 – Ovarian cancer in the elderly - the role of surgery and systemic treatment#220 – Development and implementation of a clinical cancer data collection system in WA#221 – How acceptable and beneficial do clinicians think peer review of multidisciplinary cancer teams is?#223 – Is the chemo ready yet?! Gaining efficiency in parenteral cancer chemotherapy supply at a large tertiary level hospital#224 – Where to care for childhood cancer survivors? Survivor and oncology service provider perspectives #225 – Radiotherapy access in the West Hume region: any need for a local radiation facility?#226 – Risk perception in medical imaging: Understanding the effect of two risk presentation formats on knowledge#227 – Forthcoming Prognostic Markers for Oesophageal Cancer: A Systematic Review and Meta-Analysis #228 – An exploration of the relationship between funding and patient accrual to oncology clinical trials: Additional Funding Intervention Trial (AFIT)#229 – An Estimate of the Rate of Participation by Adolescent and Young Adults (AYA) in Oncology Clinical Trials in Victoria: 2011 and 2012#23 – Treatment of Lymphomas in Patients Over 65 yrs of Age#230 – Celebrating 25 years of the Clinical Trials Management Scheme (CTMS): Victorian clinical trial activity, 1988-2013#231 – Mapping cancer pain screening, assessment and reassessment practices within one Australian health district: results from a baseline chart audit#232 – Exploring opiate errors in the specialist cancer and palliative care setting: perceptions of key stakeholders#233 – An Evidence-Based Estimation of Local Control and Survival Benefit of Radiotherapy for Colorectal Cancer#234 – Peer Review of Multidisciplinary cancer teams: a pilot study#235 – It’s Not Just a Numbers Thing – Looking for Quality in MDMs#236 – Indigenous Patients with Metastatic Lung Cancer at the Royal Darwin Hospital: An Eleven Year Audit of Data Regarding Chemotherapy, Radiotherapy and Palliative Care.#238 – Assessing cancer patients experiences of care: the Victorian experience.#239 – Development of a capability framework to support the provision of chemotherapy within a shared care model for children and adolescents with cancer#24 – Elderly Patients and glioma- navigating the gaps in the evidence#240 – Working Together: An Integrated Model of Care for Cancer Services#241 – The Challenges in Integrating Care Coordinators into Cancer Care – an Analysis of Australian Evaluation Data#242 – Does the Availability of a Local Service Change the Types of Patients Who Accesses Radiotherapy? An Investigation in the Western NSW Local Health District (WNSWLHD).#25 – Anemia in the Elderly: New Wrinkles on an Old Problem#251 – Join a Research Study Data Base#252 – Identification and predictors of physical activity barriers among gynaecological cancer survivors, and association with physical activity levels#253 – Changes in Cancer Mortality and Incidence in Australia 1987-2007#254 – Retrospective Study of Febrile Neutropenia and G-CSF use in Australian Women Receiving Docetaxel plus Cyclophosphamide (TC) as Adjuvant Therapy for Early-Stage Breast Cancer (ESBC)#255 – Understanding factors in emergency presentation for colorectal cancer surgery#256 – Indigenous Patients and Metastatic Colorectal Cancer: Results from the South Australian (SA) Metastatic Colorectal Cancer (mCRC) Registry#257 – Research Participants’ Views of the Feedback of Genetic Test Information Following Participation in the International Sarcoma Kindred Study (ISKS)#258 – Management of malignant spinal cord compression across north-eastern Melbourne#259 – Predictors of outcome after surgery for gastric cancer in a Western cohort#26 – Medication Adherence #260 – Prostate-Specific Antigen (PSA) Rate of Decline Post External Beam Radiotherapy Predicts Prostate Cancer Death#261 – The New South Wales Cancer, Lifestyle and Evaluation of Risk Study (CLEAR): A resource for cancer research.#262 – Australian data in global surveillance of population-based cancer survival (the CONCORD programme)#263 – Survival after Cutaneous Melanoma in Kidney Transplant Recipients: A Population-Based Matched Cohort Study#264 – Awareness of General and Personal Risk Factors for Uterine Cancer Among Healthy Women - A Rural Australian Study#265 – The Effect of the Ageing Population on the Distribution of Cancers#266 – Psychosocial Analysis of Cancer Survivors in Rural NSW, Australia#267 – Food Plate Waste, Dietary Intake and Malnutrition in an Inpatient Oncology Setting#268 – Engagement with online cancer support and information platforms in Australia#269 – Introducing the Nurse Practitioner Role to Improve Regional Oncology Patient Outcomes#27 – Medicine(s) Matter(s) in the Older Patient: Understanding, Counselling and Health Literacy#270 – First Australian Study of Scalp Cooling with the Dignitana Dignicap™ for Prevention of Alopecia induced by Docetaxel/Cyclophosphamide Chemotherapy in Women with Early Breast Cancer#271 – Improving Practice: Implementation and Evaluation of an Elearning Program for Health Care Professionals in Supportive Care of Cancer Patients at Peninsula Health#272 – Development and Introduction of Guidelines Regarding the Co-Administration of Azole Antifungal Agents and Vinca Alkaloids#273 – Lung Cancer: Predictors of Stigma among Health Professionals versus Community Members#274 – Development of a Nurse-Led Survivorship Intervention for Long-Term Survivors of Hodgkin Lymphoma.#276 – An Evidence-Based Nutrition Care Pathway for Surgical Head and Neck Patients#277 – The Impact of Providing Peer Support within a Research Context: A Qualitative Insight into Delivering a Combined Nurse-Peer Psychosocial Intervention for Gynaecological Cancer Patients#278 – “There are No Good Things about having a PEG tube, Except it Keeps me Alive”. Nutritional Status and Quality of Life in Long Term Home Enteral Nutrition Post Treatment Head and Neck Cancer Patients.#279 – Stigma and nihilism in lung cancer within the Australian context#28 – Medicine Matters in the Older Cancer Patient: Drug Interactions and Toxicities#280 – A Pilot Study of Tailored Nutrition and Physical Activity Intervention in Cancer Survivors#281 – A Longitudinal Psychosocial Distress Assessment in Malignant Glioma Patients and their Carers: A Comparative Study#282 – Reasons for dietary change and information and support needs in women who gain weight following chemotherapy for breast cancer#285 – "I have quality of life...but..." Exploring quality of life and support needs in head and neck cancer: An application of the Transactional Model of Stress Appraisal and Coping.#287 – Effects of a Structured Exercise Program on Pre-Operative Optimisation Prior to Major Cancer Sugery#288 – Outcomes of Haematology/Oncology Patients Admitted to Intensive Care Unit (ICU) at The Canberra Hospital (TCH)#29 – Healthcare Needs of the Senior Adult Who Lives in Urban versus Rural Communities#290 – Restorative Care for Advanced Cancer Patients: A Retrospective Clinical Audit of Outcomes for Patients Admitted to An Inpatient Palliative Care Unit#291 – Qualitative Analysis of Knowledge, Attitudes and Experiences Regarding Urinary Symptoms among Postmenopausal Women Taking Aromatase Inhibitors for Early Stage Breast Cancer#292 – Prevalence of complementary and alternative diet therapies used in patients attending oncology and haematology day units at a teaching hospital#293 – Perceived Nutritional needs of Adolescents and Young Adults with Cancer: A Survey of Dietitians and Patients#294 – A Retrospective Audit of the Nutritional Status and Management of Adolescents and Young Adults (AYAS) with Cancer During and after Treatment#295 – Timely Management of Febrile Neutropenia in Children with Cancer#296 – Oral vs. Intravenous Antibiotics in Treatment of Paediatric Febrile Neutropenia#297 – Consumer-led design of patient resources: a qualitative study of cancer resources#298 – Dose escalation of irinotecan in a patient taking rifampicin.#299 – Vemurafenib – can it be crushed or chewed?#3 – Economic challenges to manage health with aging population#30 – Is ICU an Appropriate Place for Elderly Cancer Patients?#300 – Putting supportive care on the map: The development of a supportive care multidisciplinary team meeting for cancer patients in the ambulatory setting#301 – A Single Institution's Experience in Rectal Cancer#303 – Pancreatic Cancer Quality Care - Is there Consensus Amongst Clinicians?#305 – Exercise as medicine in the management of pancreatic cancer: a case study#306 – An Estimation of the Population Survival Benefit of First-line Chemotherapy for Upper Gastrointestinal Cancer#307 – Identifying Shortcomings and Variation in the Diagnosis of Colorectal Cancer Patients#308 – Retrospective analysis of resected gastrointestinal stromal tumours (GISTs) comparing existing risk stratification models and assessing the influence of GIST genotypes on recurrence and mortality #309 – A Clinical Audit of Anal Cancer in a Single Tertiary Centre Over 10 Years#31 – Dying at home#310 – Cetuximab use in metastatic colorectal cancer at Princess Alexandra Hospital: streamlined analysis using electronic medical record data#311 – Disseminated Tumour Cells (Dtcs) in Bone Marrow (BM) of Gastric Cancer Patients with M0 Category: Correlation with Tumour Hypoxia and Clinical Relevance#312 – Is Second Line Chemotherapy in Pancreatic Cancer One Line Too Many?#313 – “Life Changing” The Lived Experience of Risk Reducing Gastrectomy in People at Risk of Hereditary Diffuse Gastric Cancer.#314 – Can Older Patients use an Electronic Tablet to Complete a Cancer Specific Geriatric Assessment? Results of a Pilot Study.#315 – Polypharmacy in the geriatric oncology setting- multidisciplinary mayhem#316 – The role of Comprehensive Geriatric Assessment in management of metastatic prostate cancer: A two centres ‘experience’#317 – Descriptive Analysis of use of Pemetrexed in Elderly NSCLC Patients – Institutional Experience at Calvary Mater Hospital, Newcastle. Dr. Sudhakar Reddy Vemula, Dr. Ina IC Nordman.#318 – Assessing Toxicity Risk in Senior Chemotherapy patients (AT RISC) – a prospective audit#319 – Evaluating the Oncology Nurse Practitioner Role: Success or Failure?#32 – Care for people living with cancer in residential aged care#320 – Brightways - A Cabrini Breast Cancer Service#321 – Development of a Nutrition Care Pathway to Improve Service Provision for Patients with an Upper Gastrointestinal Malignancy#322 – Chemotherapy Infusion Preference Survey (CHIPS): Patient Preferences for Chemotherapy Scheduling#323 – Simplifying complexity: Cancer Pharmacy Services for Chemotherapy Units in Rural South Australia#324 – Establishing Oncology Massage as Part of a Wellness Program in a Comprehensive Cancer Centre#325 – Treatment Standards Development - A Work In Progress#326 – Leveraging Technology to Strengthening the Delivery of Multidisciplinary Care: SMICS’ Multidisciplinary Team (MDT) Meeting Room Upgrade Project#327 – Bringing Healthcare Home: a patient centred approach to cancer care#328 – ICECREAM: Irinotecan Cetuximab Evaluation and the Cetuximab Response Evaluation Among Patients with G13D Mutation#329 – We Need a Trial to Evaluate Whether Patients with Involved Inguinal Lymph Nodes Should Have Inguinal or Ilio-Inguinal Lymphadenectomy; an Overview of the Proposed Trial ANZMTG 01.12 EAGLE FM Protocol#33 – Advances in Nutrition and Cancer - Symposium#330 – The CHALLENGE Trial. A Phase III Study of the Impact of a Physical Activity Program on Disease-Free Survival in Patient with High Risk Stage II or Stage III Colon Cancer: A Randomised Controlled Trial#331 – Efficacy and safety of Ginkgo biloba for cognitive function and fatigue in breast cancer patients undergoing adjuvant chemotherapy: A randomised, controlled trial#332 – Cognitive Rehabilitation for Breast Cancer Survivors with Perceived Cognitive Impairment#333 – NSW Bowel Cancer Care Survey: Population-based assessment of patients cancer care coordination needs and preferences#334 – Accrual to a Randomised Trial of Whole Brain Radiotherapy in Melanoma Brain Metastases is Feasible.#335 – Health Related Quality of Life in Mesothelioma#336 – Can a Complex Intervention Targeted at the Community and at Health Care Providers Reduce the Total Diagnostic Interval for Common Cancers in Rural WA?#337 – ANZMTG 02.12: A Phase III Trial of Imiquimod Topical Treatment Versus Radiotherapy#338 – Efficacy and Cost-Effectiveness of a Telephone Outcall Program to Reduce Carer Burden and Depression Among Carers of Cancer Patients [PROTECT]. Rationale and Design of a Multi-State, Multi-Centre Randomised Controlled Trial#339 – The Impact of Seizures on Cognition and Health Related Quality of Life in Primary Brain Tumours.#34 – Maintaining Evidence-Based Guidelines Online: Update on Nutritional Management of Patients with Head and Neck Cancer.#35 – Chemotherapy-Induced Nausea and Vomiting: A Review to Inform Clinical Practice.#36 – Overview of Evidence-Based Practice Guidelines for the Nutritional Management of Patients Receiving Anticancer Therapy#37 – Nutritional Management of Patients with Asbestos Related Diseases#38 – Managing the Knowledge Base for Oncology#39 – Effective Searching: Evidence Based Solutions#4 – Operating On The Older Patient With Cancer#40 – Developing Wiki-Based Clinical Practice Guidelines for Cancer#41 – Sustaining the Currency of the Evidence Base of eviQ#42 – Development and Implementation of Evidence-Based Nutrition Care Pathways for Upper Gastrointestinal Oncology Patients#43 – Prognostic Value of Systemic Inflammation-Based Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Modified Glasgow Prognostic Score in Advanced Pancreatic Cancer#44 – ASPECCT: A Randomised, Multicentre, Open-Label, Phase 3 Study of Panitumumab Vs Cetuximab for Previously-Treated Wild-Type (WT) KRAS Metastatic Colorectal Cancer (mCRC)#45 – Exploring potential benefit of earlier nutritional interventions in adults with upper gastrointestinal cancer: a randomised trial#46 – Family CONNECT: A randomised controlled trial to improve psychosocial outcomes for cancer carers.#47 – Ethnic Inequalities in Stomach Cancer Treatment Pathways#48 – OPTiM: a randomised phase 3 trial of talimogene laherparepvec (T-VEC) vs subcutaneous (SC) granulocyte-macrophage colony-stimulating factor (GM-CSF) for the treatment of unresected stage IIIB/C and IV melanoma#49 – Prognostic Significance, Accuracy and Usefulness of Oncologists Estimates of Survival Time for Patients Starting First Line Chemotherapy for Advanced Non-Small Cell Lung Cancer (ANSCLC)#5 – Practice Pearls: What is different when dealing with the older patient? A medical oncologist’s perspective.#50 – Treatment Outcomes of Rapid Desensitisation Protocols for Chemotherapeutic Agents and Monoclonal Antibodies following Hypersensitivity Reactions.#51 – Disease and Patient Characteristics related to Survival in a large population-based cohort of patients with Malignant Pleural Mesothelioma (MPM)#52 – Somatic Mutations in Metastatic Melanoma in a large cohort of Australian patients #53 – Prognostic Value of Early Objective Tumor Response (EOTR) to First Line Systemic Therapy in Metastatic Colorectal Cancer (Mcrc): Individual Patient Data (IPD) Meta-Analysis of Randomized Trials from the ARCAD Database#54 – Beyond Routine Staging Investigations, How to Choose the Right Patients for Oesophagectomy?#55 – The Role of Definitive Chemoradiotherapy – How to Avoid the Knife#56 – What is the optimal neoadjuvant chemotherapy regimen in resectable oesophageal cancer?#57 – At what age is multimodal therapy and surgery no longer affordable?#58 – Endoscopic diagnosis and treatment of dysplasia and early cancer in the Upper GIT#59 – Targeted therapy in oesophago-gastric cancer#6 – What is Different About Looking after Older Adults with Cancer? The Nurses' Perspective.#60 – Opportunities with Stereotactic Radiotherapy in Upper GI Cancers#61 – Operative and Non-Operative Management of Locally Advanced Oesophageal Cancer#62 – Cognition after Chemotherapy: An Overview.#63 – Chemotherapy-Induced Cognitive Impairment: Cultural Considerations#64 – Cognitive Rehabilitation Interventions#65 – Assessing mechanisms of cognitive impairment from chemotherapy using rat models#66 – Panel discussion and Case Study#67 – Familial intestinal type gastric cancer: Which genes? What surveillance?#68 – Hereditary Diffuse Gastric Cancer – Surveillance or Prophylactic Gastrectomy#69 – Familial Gastric Polyposis and Adenocarcinoma#7 – Nutrition in the older cancer patient - practical tips for screening, assessment and intervention#70 – Can I live without my stomach: long-term dietary challenges#71 – Survival of Australian women with Epithelial Ovarian Cancer – a Population-based Study#73 – Casting a long shadow: the role of household crowding on Helicobacter pylori infection, and excess stomach cancer incidence among Māori and Pacific people in New Zealand#74 – Patterns of Breast Cancer Care in Victoria: A joint Breast Cancer Quality Project.#75 – Trends in Ethnic and Socioeconomic Inequalities in Cancer Survival, New Zealand, 1991-2004#76 – Childhood Cancer in Indigenous Populations Worldwide: A Systematic Review#77 – The Effect of Biased Health Information and Consumer Attitudes on Anticipated Whole Genome Screening Uptake.#78 – Information Seeking Behaviours of Patients with Cancer#79 – A Collaborative Approach - The Next Steps: Delivering State-wide Cancer Pharmacy Training#8 – Pre-Surgical Exercise Prescription for Cancer Patients#80 – Impact of a Qstream Online Learning Module on Palliative Care Nurses’ Pain Assessment Competencies and Patients’ Reports of Pain: Results from a Quasi-Experimental Pilot Study#81 – A self-directed e-learning package for pharmacists involved in the dispensing and checking of oral anti-cancer therapies#82 – The impact of Fear of Cancer Recurrence on wellness#83 – Lobular Breast Cancer and E-cadherin#84 – Triple Negative Breast Cancer: Is it Genetic?#85 – Risk reducing bilateral mastectomy for BRCA1/2 mutation carriers#86 – PARP inhibitors and familial breast cancer#87 – Androgens: role in aging & prostate cancer - non castrate and castrate resistant states#88 – Radical Prostatectomy vs surveillance: Does age matter?#89 – Fine wine: The Old and the New in Radiation Therapy for Prostate Cancer#9 – Cancer as a Model of Accelerated Physiological Aging and Mitigating Effect of Exercise Training#90 – Castrate-Resistant Prostate Cancer: New Wine and its Challenges#91 – Outcomes versus Access: Who is Most Vulnerable? A ‘Wicked’ Issue for Cancer Surgery in Australia#92 – Patterns of Cancer Surgery in Rural Versus Urban Cancer Patients#93 – The Volume-Outcome Relationship in Cancer Surgery - Do Rural Patients have a Choice?#94 – Patterns of Mastectomy for Invasive Breast Cancer in Queensland#95 – Patient Flows in Cancer Surgery#96 – One Age Does Not Fit All: Geriatric Cancer Patients are not a Single Homogenous Group#97 – A Mortality Risk Prediction Tool for Older Adults with Lymph Node-Positive Colon Cancer#98 – Patient Selection for Radiotherapy in the Elderly Population: The Importance of Performance Status#99 – Effect of Age on Quality of Life Changes During Head and Neck Cancer Treatment